Diabetic macular oedema (DMO)

Diabetic macular oedema (DMO) is the most common cause of sight loss or even blindness in people with diabetes. Sometimes, leaky vessels can cause fluid to build up in the macula, at the centre of the retina. This swelling is known as diabetic macular oedema.

Showing all 4 results

Filter our product list:

Product Batch	Antigen	Molecular Class	Drug Brand	Product Concentration	CoA	Quantity per vial	Storage Temperature	Expiry Date	Price from
Aflibercept KT05V26	PIGF , VEGF-A	Fusion protein	Eylea®	40 mg/mL	–	0,8 mg	-80°C	2021.11	627,00 €	view product Max: 1 Min: 1 Step: 1
Aflibercept KT0KBL2	PIGF , VEGF-A	Fusion protein	Eylea®	40 mg/mL	–	0,8 mg	-80°C	2025.02	1.296,00 €	view product Max: 3 Min: 1 Step: 1
Ranibizumab	VEGF	Biosimilar , Monoclonal Antibody	Ximluci®	10 mg/mL	–	0,21 mg	tba	tba	680,00 €	view product Max: 10 Min: 5 Step: 1
Ranibizumab	VEGF	Monoclonal Antibody	Byooviz®	10 mg/mL	–	0,21 mg	tba	tba	621,00 €	view product Max: 10 Min: 5 Step: 1